首頁 > 市場調查報告書 > 醫療設備

e保健體外診斷藥物開發人工智能人工智能藥物研發診斷用人工智能

醫療保健領域的人工智慧市場：按產品、功能、應用程式、部署模型、工具、最終用戶和地區分類 - 到 2030 年的預測

市場調查報告書

商品編碼

1623607

醫療保健領域的人工智慧市場：按產品、功能、應用程式、部署模型、工具、最終用戶和地區分類 - 到 2030 年的預測

Artificial Intelligence in Healthcare Market by Offering, Function, Application, End User, Region- Global Forecast to 2030

出版日期: 2024年12月19日 | 出版商:

MarketsandMarkets | 英文 738 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球人工智慧（AI）在醫療保健領域的市場規模預計將從 2024 年的 149.2 億美元增至 2030 年的 1,641.6 億美元，預測期內複合年成長率為 49.1%。

由於公共和私人組織投資和資金籌措的增加、人工智慧在醫療保健行業的快速普及以及對開發人類感知人工智慧系統的關注，預計該市場將成長。此外，由於醫療保健專業人員與患者的比例不平衡，市場不斷成長，增加了對增強服務的需求。然而， IT基礎設施不足以及新興國家不願採用基於人工智慧的醫療保健解決方案預計將對市場成長構成挑戰。

調查範圍
調查年份	2022-2029
基準年	2023年
預測期	2024-2029
考慮單位	金額（美元）
按細分市場	按產品、按功能、按用例、按部署模型、按工具、按最終用戶、按區域
目標區域	北美、歐洲、亞太地區、拉丁美洲、中東/非洲

醫療保健領域的人工智慧 (AI) 軟體細分為本地、雲端基礎和混合模式。到 2023 年，雲端基礎的細分市場預計將在預測期內實現最高成長。雲端細分市場的成長歸因於來自各個孤島的資料的無縫整合、遠端位置的無限制用戶訪問、維護成本低、安全性高、隱私性強、易於訪問、無需前期投資硬體，極其這是由於許多此模型提供的優勢包括高容量靈活性和最佳化的資源利用率。此外，對遠端醫療服務和遠端醫療不斷成長的需求正在加速雲端技術的採用，這些技術有助於醫療保健專業人員輕鬆存取影像處理工具和資料共用，從而進一步促進該領域的成長。

到 2023 年，醫院和診所將在最終用戶的醫療保健人工智慧 (AI) 市場中佔據很大佔有率。此細分市場的突出地位是由於個人化醫療的推動、對準確診斷和手術計劃的需求、微創手術的興起以及與現有系統互通性的需求。人工智慧的應用，例如臨床決策支援系統、病患結果的預測分析和自動化管理工作流程，可以解決勞動力短缺和病患人數成長等關鍵挑戰。此外，醫學影像的進步、與 EHR 系統的整合以及政府對人工智慧主導的醫療保健轉型的支持正在進一步推動採用。

預計亞太地區在預測期內將實現最高成長。該地區的高成長是由該地區龐大且不斷成長的患者人口、對創新治療的需求不斷成長、醫療保健巨量資料的出現、HCIT 基礎設施支出的增加以及各個市場參與企業的重點轉向新興經濟體推動的。政府努力加快在整個醫療保健行業採用數位技術支援的解決方案，並更加重視跨工作流程整合先進技術，這也有助於促進成長。

這份報告研究了全球醫療保健領域的人工智慧 (AI) 市場，包括按功能、應用程式、部署模型、工具、最終用戶、地區以及進入市場的公司概況分類的趨勢。

介紹
市場動態
影響客戶業務的趨勢/干擾
技術分析
產業動態
價格分析
價值鏈分析
生態系分析
專利分析
2024-2025年重大會議和活動
案例研究分析
監管狀況
波特五力分析
主要相關人員和採購標準
最終用戶分析
醫療保健經營模式中的人工智慧
投資金籌措場景
生成式人工智慧對醫療保健領域人工智慧市場的影響

第6章醫療保健領域的人工智慧市場（依產品分類）

介紹
綜合解決方案
利基/點解決方案
人工智慧技術
服務

第7章醫療保健領域的人工智慧市場（按功能）

介紹
診斷和早期發現
治療計劃和個性化
病人參與和遠端監控
治療後監測和倖存者護理
藥局管理
資料管理與分析
行政

第8章醫療保健領域的人工智慧市場（按應用）

介紹
臨床
非臨床

第 9 章醫療保健領域的人工智慧市場（按部署模型）

介紹
本地部署模式
雲端基礎的模型
混合模式

第 10 章醫療保健領域的人工智慧市場（按工具）

介紹
機器學習
自然語言處理（NLP）
上下文感知計算
人工智慧世代
電腦視覺
影像分析

第 11 章醫療保健領域的人工智慧市場（按最終用戶）

介紹
醫療服務提供方
醫療保健付款人
病人
其他

第12章醫療保健人工智慧市場（按地區）

介紹
北美洲
- 北美宏觀經濟展望
- 美國
- 加拿大
歐洲
- 歐洲宏觀經濟展望
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
亞太地區
- 亞太宏觀經濟展望
- 中國
- 日本
- 印度
- 其他
拉丁美洲
- 拉丁美洲宏觀經濟展望
- 巴西
- 墨西哥
- 其他
中東/非洲
- 中東和非洲的宏觀經濟前景
- 海灣合作理事會國家
- 其他

第13章競爭格局

介紹
主要參與企業的策略/優勢
2019-2023年收益分析
2023 年市場佔有率分析
企業評估矩陣：主要參與企業，2023
企業評估矩陣：Start-Ups/小型企業，2023 年
公司評價及財務指標
品牌/產品比較
競爭場景

第14章公司簡介

主要參與企業
- KONINKLIJKE PHILIPS NV
- MICROSOFT CORPORATION
- NVIDIA CORPORATION
- SIEMENS HEALTHINEERS AG
- GE HEALTHCARE
- EPIC SYSTEMS CORPORATION
- ORACLE
- VERADIGM LLC
- AMAZON WEB SERVICES, INC.
- MERATIVE（IBM）
- MEDTRONIC
- GOOGLE
- SOPHIA GENETICS
- JOHNSON & JOHNSON SERVICES, INC.
- TEMPUS
- TERARECON（CONCERTAI）
- 3M
- COGNIZANT
- VIZ.AI, INC.
- RIVERAIN TECHNOLOGIES
其他公司
- QVENTUS
- QURE.AI
- ATOMWISE INC.
- ENLITIC
- SEGMED

第15章附錄

簡介目錄圖表

Product Code: HIT 9226

The global Artificial Intelligence (AI) in healthcare market is projected to reach USD 164.16 billion by 2030 from USD 14.92 billion in 2024, at a CAGR of 49.1% during the forecast period. The market is expected to grow as a result of the increasing investments & funding by public-private organizations, the rapid proliferation of AI in the healthcare industry, and the increasing focus on developing human-aware AI systems. Moreover, the market has experienced growth due to rising demand for enhanced services due to a disproportionate ratio between the healthcare workforce and patient numbers. However, insufficient IT infrastructure, and reluctance towards adoption of AI-based healthcare solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	By Offering, Function, Application, Deployment, Tools, End User
Regions covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

"Cloud-based segment is expected to register highest growth during the forecast period, by deployment."

The Artificial Intelligence (AI) in healthcare software segment is segmented into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment's growth.

"Hospitals & Clinics dominated the market in the Artificial Intelligence (AI) in healthcare market for healthcare providers, by end user in 2023."'

The hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers make up the healthcare providers segment of the end user of the Artificial Intelligence (AI) in healthcare market. In 2023, the hospitals & clinics accounted for a significant share of the Artificial Intelligence (AI) in healthcare market, by end user. The prominent position of this segment is due to the push for personalized medicine, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. AI applications, such as clinical decision support systems, predictive analytics for patient outcomes, and automated administrative workflows, address critical challenges like workforce shortages and rising patient loads. Additionally, advancements in medical imaging, integration with EHR systems, and government support for AI-driven healthcare transformation further encourage adoption.

"Asia Pacific is expected to register highest market growth during the forecast period."

The Artificial Intelligence (AI) in healthcare market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The high growth of this region is attributed to the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across the healthcare industry and a significant focus on integrating sophisticated technologies across the workflows also contribute to the growth.

The break-down of primary participants is as mentioned below:

By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
By Designation - Directors: 30%, Manager: 34%, and Others: 36%
By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

Koninklijke Philips N.V. (Netherlands)
Microsoft (US)
Siemens Healthineers AG (Germany)
NVIDIA Corporation (US)
Epic Systems Corporation (US)
GE Healthcare (US)
Medtronic (US)
Oracle (US)
Change Healthcare (US)
Veradigm LLC (US)
Merative (IBM) (US)
Google (US)
Cognizant (US)
Johnsons & Johnsons (US)
Amazon Web Services, Inc. (US)
SOPHiA GENETICS (US)
Riverian Technologies (US)
Terarecon (ConcertAI) (US)
3M (US)
Tempus (US)
Viz.ai (US)
Recursion (US)
Qure.ai (India)
Atomwise Inc. (US)
Entilic (US)
Personify Health (US)

Research Coverage:

The report analyzes the Artificial Intelligence (AI) in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Artificial Intelligence (AI) in healthcare market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of key drivers (exponential growth in data volume and complexity due to surging adoption of digital technologies, significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases, rapid proliferation of AI in healthcare sector, growing need for improvised healthcare services), restraints (reluctance among medical practitioners to adopt AI-based technologies, shortage of skilled AI professionals handling AI-powered solutions, lack of standardized frameworks for AL and ML technologies), opportunities (increasing use of AI-powered solutions in elderly care, increasing focus on developing human-aware AI systems, rising use of technology in pharmaceuticals industry, strategic partnerships and collaborations among healthcare companies and AI technology providers), challenges (inaccurate predictions due to scarcity of high-quality healthcare data, concerns regarding data privacy, lack of interoperability between AI solutions offered by different vendors) are factors contributing the growth of the Artificial Intelligence (AI) in healthcare market.
Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Artificial Intelligence (AI) in healthcare market.
Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Artificial Intelligence (AI) in healthcare market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Artificial Intelligence (AI) in healthcare market such as Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US).

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 AI IN HEALTHCARE MARKET OVERVIEW
4.2 ASIA PACIFIC: AI IN HEALTHCARE, BY OFFERING AND COUNTRY (2024)
4.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 AI IN HEALTHCARE MARKET: REGIONAL MIX (2022-2030)
4.5 AI IN HEALTHCARE: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing need for early detection and diagnosis
  - 5.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies
  - 5.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases
  - 5.2.1.4 Rapid proliferation of AI in healthcare sector
  - 5.2.1.5 Growing need for improvised healthcare services
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies
  - 5.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions
  - 5.2.2.3 Lack of standardized frameworks for AL and ML technologies
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Increasing use of AI-powered solutions in elderly care
  - 5.2.3.2 Increasing focus on developing human-aware AI systems
  - 5.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers
- 5.2.4 CHALLENGES
  - 5.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data
  - 5.2.4.2 Concerns regarding data privacy
  - 5.2.4.3 Lack of interoperability between AI solutions offered by different vendors
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
  - 5.4.1.1 Machine learning (ML) & deep learning
  - 5.4.1.2 Natural language processing (NLP)
  - 5.4.1.3 Computer vision (CV)
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
  - 5.4.2.1 Cloud computing
  - 5.4.2.2 Digital twins
  - 5.4.2.3 Robotic process automation (RPA)
- 5.4.3 ADJACENT TECHNOLOGIES
  - 5.4.3.1 Blockchain
  - 5.4.3.2 Augmented and virtual reality (AR/VR)
  - 5.4.3.3 Internet of things (IoT)
5.5 INDUSTRY TRENDS
- 5.5.1 SHIFT TOWARD PERSONALIZED MEDICINE
- 5.5.2 AI IN DIAGNOSTICS AND IMAGING
5.6 PRICING ANALYSIS
- 5.6.1 INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE)
- 5.6.2 INDICATIVE PRICE TREND, BY REGION
5.7 VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.9 PATENT ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2024-2025
5.11 CASE STUDY ANALYSIS
- 5.11.1 BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19
- 5.11.2 MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE
- 5.11.3 TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS
- 5.11.4 GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA
5.12 REGULATORY LANDSCAPE
- 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.12.2 REGULATORY FRAMEWORK
  - 5.12.2.1 North America
  - 5.12.2.2 Europe
  - 5.12.2.3 Asia Pacific
  - 5.12.2.4 Middle East & Africa
  - 5.12.2.5 Latin America
5.13 PORTER'S FIVE FORCES ANALYSIS
- 5.13.1 THREAT OF NEW ENTRANTS
- 5.13.2 THREAT OF SUBSTITUTES
- 5.13.3 BARGAINING POWER OF SUPPLIERS
- 5.13.4 BARGAINING POWER OF BUYERS
- 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.14.2 BUYING CRITERIA
5.15 END-USER ANALYSIS
- 5.15.1 UNMET NEEDS
- 5.15.2 END-USER EXPECTATIONS
5.16 AI IN HEALTHCARE BUSINESS MODELS
- 5.16.1 SOFTWARE-AS-A-SERVICE (SAAS) MODEL
- 5.16.2 LICENSING MODEL
- 5.16.3 REVENUE SHARING/OUTCOME-BASED MODEL
- 5.16.4 FREEMIUM MODEL
- 5.16.5 AI-AS-A-SERVICE (AIAAS) MODEL
- 5.16.6 PARTNERSHIP/REVENUE-SHARING MODEL
- 5.16.7 HYBRID MODELS
- 5.16.8 PAY-PER-USE MODELS
5.17 INVESTMENT & FUNDING SCENARIO
5.18 IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET
- 5.18.1 INTRODUCTION
- 5.18.2 MARKET POTENTIAL OF GEN AI IN HEALTHCARE
  - 5.18.2.1 Key use cases of Gen AI
- 5.18.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
  - 5.18.3.1 Eka Care leveraging generative AI for improved health outcomes
- 5.18.4 INTERCONNECTED AND ADJACENT ECOSYSTEMS
  - 5.18.4.1 AI in healthcare IT
  - 5.18.4.2 AI in medical diagnostics
  - 5.18.4.3 AI in oncology
  - 5.18.4.4 AI in clinical trials
  - 5.18.4.5 AI in drug discovery
- 5.18.5 USER READINESS & IMPACT ASSESSMENT
  - 5.18.5.1 User readiness
    - 5.18.5.1.1 Healthcare providers
    - 5.18.5.1.2 Healthcare payers
    - 5.18.5.1.3 Patients
  - 5.18.5.2 Impact assessment
    - 5.18.5.2.1 User A: Healthcare providers
      - 5.18.5.2.1.1 Implementation
      - 5.18.5.2.1.2 Impact
    - 5.18.5.2.2 User B: Healthcare payers
      - 5.18.5.2.2.1 Implementation
      - 5.18.5.2.2.2 Impact
    - 5.18.5.2.3 User C: Patients
      - 5.18.5.2.3.1 Implementation
      - 5.18.5.2.3.2 Impact

6 AI IN HEALTHCARE MARKET, BY OFFERING

6.1 INTRODUCTION
6.2 INTEGRATED SOLUTIONS
- 6.2.1 RISING WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION
6.3 NICHE/POINT SOLUTIONS
- 6.3.1 TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET
6.4 AI TECHNOLOGIES
- 6.4.1 ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH
6.5 SERVICES
- 6.5.1 NEED FOR EMPOWERING NON-CLINICAL HEALTHCARE OPERATIONS TO ACCELERATE MARKET GROWTH

7 AI IN HEALTHCARE MARKET, BY FUNCTION

7.1 INTRODUCTION
7.2 DIAGNOSIS & EARLY DETECTION
- 7.2.1 PRE-SCREENING
  - 7.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market
- 7.2.2 IVD
  - 7.2.2.1 IVD market: By technology
    - 7.2.2.1.1 Immunoassays
      - 7.2.2.1.1.1 Increasing focus on individualized therapies to drive market
    - 7.2.2.1.2 Clinical chemistry
      - 7.2.2.1.2.1 Increased demand for precision medicine and efficient healthcare systems to drive market
    - 7.2.2.1.3 Molecular diagnostics
      - 7.2.2.1.3.1 Improved disease detection, personalized treatments, and enhanced outcomes to fuel growth
  - 7.2.2.2 IVD market: By application
    - 7.2.2.2.1 Image analysis & interpretation
      - 7.2.2.2.1.1 Advantages such as enhanced diagnostic accuracy, faster detection, and improved patient outcomes to support growth
    - 7.2.2.2.2 Biomarker discovery & analysis
      - 7.2.2.2.2.1 Ability of AI-based biomarker discovery to enhance disease detection, prognosis, and personalized treatment to drive adoption
    - 7.2.2.2.3 Other IVD applications
- 7.2.3 DIAGNOSTIC IMAGING
  - 7.2.3.1 Diagnostic imaging market: By application
    - 7.2.3.1.1 Disease interpretation & report analysis
      - 7.2.3.1.1.1 Ability of AI-driven disease interpretation to accelerate diagnosis, treatment, and outcomes to fuel growth
    - 7.2.3.1.2 Image captioning & annotation
      - 7.2.3.1.2.1 Enhanced diagnostic accuracy, efficiency, and consistency associated with image captioning & annotation to boost market
    - 7.2.3.1.3 Image reconstruction
      - 7.2.3.1.3.1 Improved diagnostic precision, efficiency, and image quality in healthcare to drive market
    - 7.2.3.1.4 Other diagnostic imaging applications
  - 7.2.3.2 Diagnostic imaging market: By modality
    - 7.2.3.2.1 Magnetic resonance imaging (MRI)
      - 7.2.3.2.1.1 Rising technological advancements to drive adoption of AI in MRI
    - 7.2.3.2.2 Computed tomography (CT)
      - 7.2.3.2.2.1 Rising availability of cardiac CT devices enabled with AI solutions to drive market
    - 7.2.3.2.3 X-ray imaging
      - 7.2.3.2.3.1 Innovative AI solutions for X-ray imaging by key players to drive market
    - 7.2.3.2.4 Ultrasound
      - 7.2.3.2.4.1 Increasing prevalence of ovarian cancer to drive market
    - 7.2.3.2.5 Nuclear imaging (PET & SPECT)
      - 7.2.3.2.5.1 Critical role played by PET and SPECT in visualizing metabolic processes to contribute to growth
    - 7.2.3.2.6 Other diagnostic imaging modalities
- 7.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION
  - 7.2.4.1 AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care
- 7.2.5 DRUG ALLERGY ALERTING
  - 7.2.5.1 Ability of AI-enhanced drug allergy alerting to improve accuracy, patient safety, and personalized care in healthcare to boost market
- 7.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS
7.3 TREATMENT PLANNING & PERSONALIZATION
- 7.3.1 PERSONALIZED TREATMENT PLANNING
  - 7.3.1.1 Precision medicine & genomic analysis
    - 7.3.1.1.1 Advantages such as accurate disease predictions and improved outcomes to drive demand
  - 7.3.1.2 Predictive models for treatment response
    - 7.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth
  - 7.3.1.3 Treatment recommendation systems
    - 7.3.1.3.1 Optimized healthcare delivery associated with treatment recommendation systems to support growth
- 7.3.2 PHARMACOLOGICAL THERAPY
  - 7.3.2.1 Drug response prediction
    - 7.3.2.1.1 Growing use of drug response prediction to minimize adverse reactions to aid growth
  - 7.3.2.2 Dosing & administration
    - 7.3.2.2.1 Improved efficacy and outcomes to fuel adoption
  - 7.3.2.3 Other pharmacological therapy functions
- 7.3.3 SURGICAL THERAPY
  - 7.3.3.1 Preoperative imaging & 3D modeling
    - 7.3.3.1.1 Enhanced surgical planning and precision to propel market
  - 7.3.3.2 Intraoperative guidance & robotics
    - 7.3.3.2.1 Faster recovery time to boost adoption
  - 7.3.3.3 Postoperative analysis & recovery
    - 7.3.3.3.1 Reduced complications to drive market
- 7.3.4 RADIATION THERAPY
  - 7.3.4.1 Motion synchronization & auto contouring
    - 7.3.4.1.1 Optimized radiation therapy with motion synchronization & auto contouring to boost market
  - 7.3.4.2 Real-time adaptive treatment delivery
    - 7.3.4.2.1 Reduced side effects to propel demand
  - 7.3.4.3 Response assessment & quality assurance
    - 7.3.4.3.1 Ability of AI to enhance response assessment and QA to spur growth
  - 7.3.4.4 Other radiation therapy functions
- 7.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY
  - 7.3.5.1 Virtual counseling & chatbots
    - 7.3.5.1.1 Ability to engage patients remotely to drive market demand
  - 7.3.5.2 Progress monitoring & feedback
    - 7.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market
  - 7.3.5.3 Follow-up & long-term support
    - 7.3.5.3.1 Widespread adoption of telemedicine platforms to drive market demand
- 7.3.6 IMMUNOTHERAPY
  - 7.3.6.1 Real-time patient data monitoring
    - 7.3.6.1.1 Need for real-time data analysis to make informed decisions to boost market growth
  - 7.3.6.2 Response & side-effect prediction
    - 7.3.6.2.1 Ability to reduce trial and error approach in medical treatments to drive market growth
  - 7.3.6.3 Relapse prediction & long-term management
    - 7.3.6.3.1 Need for proactive approach for long-term care to fuel market growth
- 7.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS
7.4 PATIENT ENGAGEMENT & REMOTE MONITORING
- 7.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE
  - 7.4.1.1 Rising prevalence of chronic diseases to drive market growth
- 7.4.2 TELEHEALTH & REMOTE PATIENT MONITORING
  - 7.4.2.1 Ability to monitor and evaluate patients remotely to boost market demand
- 7.4.3 HEALTHCARE ASSISTANCE ROBOTS
  - 7.4.3.1 Advancements in robotics and artificial intelligence (AI) to boost market demand
- 7.4.4 MEDICATION REMINDERS
  - 7.4.4.1 Increasing adoption of smartphone applications and IoT devices to surge market demand
- 7.4.5 PATIENT EDUCATION & EMPOWERMENT
  - 7.4.5.1 Need to improve treatment adherence and enhance self-management to drive market growth
- 7.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS
7.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE
- 7.5.1 RECURRENCE MONITORING
  - 7.5.1.1 Need to predict recurrence of cancer to drive market
- 7.5.2 LONG-TERM OUTCOME PREDICTION
  - 7.5.2.1 Ability to predict long-term health outcomes and enhance patient care to drive market
- 7.5.3 MENTAL HEALTH & SUPPORT SYSTEMS
  - 7.5.3.1 Need to help patients cope with mental strain to drive market
7.6 PHARMACY MANAGEMENT
- 7.6.1 EPRESCRIBING
  - 7.6.1.1 Need to improve safety and efficiency in prescribing to drive market
- 7.6.2 MEDICATION MANAGEMENT
  - 7.6.2.1 Ability to predict adverse drug reactions by patient data analysis to drive market
- 7.6.3 PHARMACY AUDIT & ANALYSIS
  - 7.6.3.1 Need for effective and efficient operation of pharmacies to drive market
- 7.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS
7.7 DATA MANAGEMENT & ANALYTICS
- 7.7.1 ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET
7.8 ADMINISTRATIVE
- 7.8.1 PATIENT REGISTRATION & SCHEDULING
  - 7.8.1.1 Need to optimize patient registration process to drive market
- 7.8.2 PATIENT ELIGIBILITY & AUTHORIZATION
  - 7.8.2.1 Need to reduce administrative burden to drive market
- 7.8.3 BILLING & CLAIMS MANAGEMENT
  - 7.8.3.1 Need to make billing process more accurate, efficient, and transparent to drive market
- 7.8.4 WORKFORCE MANAGEMENT
  - 7.8.4.1 Need for effective staff management to drive market
- 7.8.5 SUPPLY CHAIN & INVENTORY MANAGEMENT
  - 7.8.5.1 Ability to make better procurement decisions to drive market
- 7.8.6 COMPLIANCE & DOCUMENTATION
  - 7.8.6.1 Need to reduce manual paperwork and errors to drive market
- 7.8.7 HEALTHCARE WORKFLOW MANAGEMENT
  - 7.8.7.1 Need to optimize and automate processes within healthcare facilities to drive market
- 7.8.8 ASSET MANAGEMENT
  - 7.8.8.1 Ability to optimize use and allocation of resources to drive market
- 7.8.9 CUSTOMER RELATIONSHIP MANAGEMENT
  - 7.8.9.1 Enhancing patient engagement and retention through AI-driven CRM systems to boost market
- 7.8.10 FRAUD DETECTION & RISK MANAGEMENT
  - 7.8.10.1 Need to enhance security in healthcare systems to drive market demand
- 7.8.11 CYBERSECURITY
  - 7.8.11.1 Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth
- 7.8.12 OTHER ADMINISTRATIVE FUNCTIONS

8 AI IN HEALTHCARE MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 CLINICAL APPLICATIONS
- 8.2.1 ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH
8.3 NON-CLINICAL APPLICATIONS
- 8.3.1 ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDENS AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH

9 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL

9.1 INTRODUCTION
9.2 ON-PREMISE MODELS
- 9.2.1 ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS
9.3 CLOUD-BASED MODELS
- 9.3.1 SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY
9.4 HYBRID MODELS
- 9.4.1 FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS

10 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL

10.1 INTRODUCTION
10.2 MACHINE LEARNING
- 10.2.1 DEEP LEARNING
  - 10.2.1.1 Convolutional neural networks (CNN)
    - 10.2.1.1.1 Growing demand for advance medical imaging and diagnostics to drive market growth
  - 10.2.1.2 Recurrent neural networks (RNN)
    - 10.2.1.2.1 Ability of RNN to enhance predictive analytics in healthcare to boost market
  - 10.2.1.3 Generative adversarial networks (GAN)
    - 10.2.1.3.1 Ability to transform data scarcity and privacy in AI-driven healthcare to drive demand for GAN
  - 10.2.1.4 Graph neural networks (GNN)
    - 10.2.1.4.1 Ability of GNN to revolutionize relational insights in healthcare analytics to fuel growth
  - 10.2.1.5 Other deep learning tools
- 10.2.2 SUPERVISED LEARNING
  - 10.2.2.1 Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools
- 10.2.3 REINFORCEMENT LEARNING
  - 10.2.3.1 Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth
- 10.2.4 UNSUPERVISED LEARNING
  - 10.2.4.1 Ability of unsupervised learning to drive innovation in healthcare analytics to propel market
- 10.2.5 OTHER MACHINE LEARNING TOOLS
10.3 NATURAL LANGUAGE PROCESSING (NLP)
- 10.3.1 SENTIMENT ANALYSIS
  - 10.3.1.1 Enhanced patient experience and operational insights to spur demand for sentiment analysis
- 10.3.2 PATTERN & IMAGE RECOGNITION
  - 10.3.2.1 Increased precision in clinical decision-making associated with pattern & image recognition to aid market
- 10.3.3 AUTO CODING
  - 10.3.3.1 Advantages such as improved medical billing and administrative efficiency to boost market
- 10.3.4 CLASSIFICATION & CATEGORIZATION
  - 10.3.4.1 Ability of classification & categorization to organize healthcare data for better outcomes to propel market
- 10.3.5 TEXT ANALYTICS
  - 10.3.5.1 Ability to transform unstructured data into actionable healthcare insights to fuel growth
- 10.3.6 SPEECH RECOGNITION
  - 10.3.6.1 Improved speech recognition advancing real-time documentation and accessibility to drive demand
10.4 CONTEXT-AWARE COMPUTING
- 10.4.1 DEVICE CONTEXT
  - 10.4.1.1 Real-time monitoring and decision-making to contribute to market growth
- 10.4.2 USER CONTEXT
  - 10.4.2.1 Personalized healthcare and adaptive workflows to drive demand
- 10.4.3 PHYSICAL CONTEXT
  - 10.4.3.1 Location-based services associated with physical context to generate demand
10.5 GENERATIVE AI
- 10.5.1 ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET
10.6 COMPUTER VISION
- 10.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION
10.7 IMAGE ANALYSIS
- 10.7.1 STREAMLINING DOCUMENT MANAGEMENT TO PROPEL MARKET

11 AI IN HEALTHCARE MARKET, BY END USER

11.1 INTRODUCTION
11.2 HEALTHCARE PROVIDERS
- 11.2.1 HOSPITALS & CLINICS
  - 11.2.1.1 Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals
- 11.2.2 AMBULATORY CARE CENTERS
  - 11.2.2.1 Supportive government norms and incentives for HCIT solutions and services to drive market growth
- 11.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES
  - 11.2.3.1 Growing need for long-term home care to drive market growth
- 11.2.4 DIAGNOSTIC & IMAGING CENTERS
  - 11.2.4.1 Growing burden of various chronic diseases to propel market growth
- 11.2.5 PHARMACIES
  - 11.2.5.1 Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies
- 11.2.6 OTHER HEALTHCARE PROVIDERS
11.3 HEALTHCARE PAYERS
- 11.3.1 PUBLIC PAYERS
  - 11.3.1.1 Focus on developing outcome-based payment models to drive demand for payer solutions
- 11.3.2 PRIVATE PAYERS
  - 11.3.2.1 Possible increases in operational efficiency to boost demand among private payers
11.4 PATIENTS
- 11.4.1 RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET
11.5 OTHER END USERS

12 AI IN HEALTHCARE MARKET, BY REGION

12.1 INTRODUCTION
12.2 NORTH AMERICA
- 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 12.2.2 US
  - 12.2.2.1 Rising adoption of advanced medical imaging and regulatory support to drive market
- 12.2.3 CANADA
  - 12.2.3.1 Growing burden of chronic diseases and research grants for AI to drive market growth
12.3 EUROPE
- 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 12.3.2 GERMANY
  - 12.3.2.1 Advanced healthcare system and government efforts to drive growth
- 12.3.3 UK
  - 12.3.3.1 Government support and new AI platform emergence to boost market
- 12.3.4 FRANCE
  - 12.3.4.1 Thriving AI ecosystem and strategic partnerships to boost healthcare innovation
- 12.3.5 ITALY
  - 12.3.5.1 Regulatory reforms, strategic investments, and aging population to propel growth
- 12.3.6 SPAIN
  - 12.3.6.1 Established network of research centers to propel market
- 12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
- 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 12.4.2 CHINA
  - 12.4.2.1 Expanding AI applications in medical imaging and diagnostics to drive market growth
- 12.4.3 JAPAN
  - 12.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI
- 12.4.4 INDIA
  - 12.4.4.1 Favorable government initiatives for R&D investments to drive market
- 12.4.5 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
- 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 12.5.2 BRAZIL
  - 12.5.2.1 AI initiatives to drive healthcare innovation and accessibility
- 12.5.3 MEXICO
  - 12.5.3.1 AI to revolutionize healthcare delivery and outcomes
- 12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
- 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 12.6.2 GCC COUNTRIES
  - 12.6.2.1 AI-driven innovations and rising healthcare investments to propel market growth
- 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET
13.3 REVENUE ANALYSIS, 2019-2023
13.4 MARKET SHARE ANALYSIS, 2023
- 13.4.1 RANKING OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 13.5.5.1 Company footprint
  - 13.5.5.2 Region footprint
  - 13.5.5.3 Application footprint
  - 13.5.5.4 Tool footprint
  - 13.5.5.5 Function footprint
  - 13.5.5.6 Offering footprint
  - 13.5.5.7 Deployment footprint
  - 13.5.5.8 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION & FINANCIAL METRICS
- 13.7.1 FINANCIAL METRICS
- 13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 OTHER DEVELOPMENTS

14 COMPANY PROFILES

14.1 KEY PLAYERS
- 14.1.1 KONINKLIJKE PHILIPS N.V.
  - 14.1.1.1 Business overview
  - 14.1.1.2 Products & services offered
  - 14.1.1.3 Recent developments
    - 14.1.1.3.1 Product launches
    - 14.1.1.3.2 Deals
    - 14.1.1.3.3 Expansions
    - 14.1.1.3.4 Other developments
  - 14.1.1.4 MnM view
    - 14.1.1.4.1 Right to win
    - 14.1.1.4.2 Strategic choices
    - 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 MICROSOFT CORPORATION
  - 14.1.2.1 Business overview
  - 14.1.2.2 Products & services offered
  - 14.1.2.3 Recent developments
    - 14.1.2.3.1 Product launches
    - 14.1.2.3.2 Deals
  - 14.1.2.4 MnM view
    - 14.1.2.4.1 Right to win
    - 14.1.2.4.2 Strategic choices
    - 14.1.2.4.3 Weaknesses & competitive threats
- 14.1.3 NVIDIA CORPORATION
  - 14.1.3.1 Business overview
  - 14.1.3.2 Products & services offered
  - 14.1.3.3 Recent developments
    - 14.1.3.3.1 Product launches
    - 14.1.3.3.2 Deals
  - 14.1.3.4 MnM view
    - 14.1.3.4.1 Right to win
    - 14.1.3.4.2 Strategic choices
    - 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 SIEMENS HEALTHINEERS AG
  - 14.1.4.1 Business overview
  - 14.1.4.2 Products & services offered
  - 14.1.4.3 Recent developments
    - 14.1.4.3.1 Product launches & enhancements
    - 14.1.4.3.2 Deals
    - 14.1.4.3.3 Other developments
  - 14.1.4.4 MnM view
    - 14.1.4.4.1 Right to win
    - 14.1.4.4.2 Strategic choices
    - 14.1.4.4.3 Weaknesses & competitive threats
- 14.1.5 GE HEALTHCARE
  - 14.1.5.1 Business overview
  - 14.1.5.2 Products & services offered
  - 14.1.5.3 Recent developments
    - 14.1.5.3.1 Deals
- 14.1.6 EPIC SYSTEMS CORPORATION
  - 14.1.6.1 Business overview
  - 14.1.6.2 Products & services offered
  - 14.1.6.3 Recent developments
    - 14.1.6.3.1 Deals
- 14.1.7 ORACLE
  - 14.1.7.1 Business overview
  - 14.1.7.2 Products & services offered
  - 14.1.7.3 Recent developments
    - 14.1.7.3.1 Product launches
    - 14.1.7.3.2 Deals
- 14.1.8 VERADIGM LLC
  - 14.1.8.1 Business overview
  - 14.1.8.2 Products & services offered
  - 14.1.8.3 Recent developments
    - 14.1.8.3.1 Deals
- 14.1.9 AMAZON WEB SERVICES, INC.
  - 14.1.9.1 Business overview
  - 14.1.9.2 Products & services offered
  - 14.1.9.3 Recent developments
    - 14.1.9.3.1 Product launches
    - 14.1.9.3.2 Deals
- 14.1.10 MERATIVE (IBM)
  - 14.1.10.1 Business overview
  - 14.1.10.2 Products & services offered
  - 14.1.10.3 Recent developments
    - 14.1.10.3.1 Product launches
    - 14.1.10.3.2 Deals
- 14.1.11 MEDTRONIC
  - 14.1.11.1 Business overview
  - 14.1.11.2 Products & services offered
  - 14.1.11.3 Recent developments
    - 14.1.11.3.1 Deals
- 14.1.12 GOOGLE
  - 14.1.12.1 Business overview
  - 14.1.12.2 Products & services offered
  - 14.1.12.3 Recent developments
    - 14.1.12.3.1 Product launches
    - 14.1.12.3.2 Deals
    - 14.1.12.3.3 Other developments
- 14.1.13 SOPHIA GENETICS
  - 14.1.13.1 Business overview
  - 14.1.13.2 Products & services offered
  - 14.1.13.3 Recent developments
    - 14.1.13.3.1 Deals
- 14.1.14 JOHNSON & JOHNSON SERVICES, INC.
  - 14.1.14.1 Business overview
  - 14.1.14.2 Products & services offered
  - 14.1.14.3 Recent developments
    - 14.1.14.3.1 Deals
- 14.1.15 TEMPUS
  - 14.1.15.1 Business overview
  - 14.1.15.2 Products & services offered
  - 14.1.15.3 Recent developments
    - 14.1.15.3.1 Product launches & approvals
    - 14.1.15.3.2 Deals
- 14.1.16 TERARECON (CONCERTAI)
  - 14.1.16.1 Business overview
  - 14.1.16.2 Products & services offered
  - 14.1.16.3 Recent developments
    - 14.1.16.3.1 Product launches & upgrades
    - 14.1.16.3.2 Deals
- 14.1.17 3M
  - 14.1.17.1 Business overview
  - 14.1.17.2 Products & services offered
  - 14.1.17.3 Recent developments
    - 14.1.17.3.1 Deals
- 14.1.18 COGNIZANT
  - 14.1.18.1 Business overview
  - 14.1.18.2 Products & services offered
  - 14.1.18.3 Recent developments
    - 14.1.18.3.1 Product launches & upgrades
    - 14.1.18.3.2 Deals
- 14.1.19 VIZ.AI, INC.
  - 14.1.19.1 Business overview
  - 14.1.19.2 Products & services offered
  - 14.1.19.3 Recent developments
    - 14.1.19.3.1 Product launches
    - 14.1.19.3.2 Deals
    - 14.1.19.3.3 Other developments
- 14.1.20 RIVERAIN TECHNOLOGIES
  - 14.1.20.1 Business overview
  - 14.1.20.2 Products & services offered
  - 14.1.20.3 Recent developments
    - 14.1.20.3.1 Deals
14.2 OTHER PLAYERS
- 14.2.1 QVENTUS
- 14.2.2 QURE.AI
- 14.2.3 ATOMWISE INC.
- 14.2.4 ENLITIC
- 14.2.5 SEGMED

15 APPENDIX

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

簡介目錄圖表

List of Tables

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2 AI IN HEALTHCARE MARKET: RISK ASSESSMENT
TABLE 3 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS
TABLE 4 AI IN HEALTHCARE MARKET: AVERAGE SELLING PRICE, BY REGION (2021-2023)
TABLE 5 COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM
TABLE 6 AI IN HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS
TABLE 7 AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2024-2025
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 14 UNMET NEEDS IN AI IN HEALTHCARE MARKET
TABLE 15 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET
TABLE 16 AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 17 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 18 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 19 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 20 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 21 AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 22 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 23 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 24 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2022-2030 (USD MILLION)
TABLE 25 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2022-2030 (USD MILLION)
TABLE 26 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 27 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2022-2030 (USD MILLION)
TABLE 28 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022-2030 (USD MILLION)
TABLE 29 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 30 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 31 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 32 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 33 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 34 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2022-2030 (USD MILLION)
TABLE 35 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 36 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 37 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 38 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2022-2030 (USD MILLION)
TABLE 39 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 40 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 41 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2022-2030 (USD MILLION)
TABLE 42 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2022-2030 (USD MILLION)
TABLE 43 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2022-2030 (USD MILLION)
TABLE 44 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2022-2030 (USD MILLION)
TABLE 45 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT), BY REGION, 2022-2030 (USD MILLION)
TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 47 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 48 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2022-2030 (USD MILLION)
TABLE 49 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 50 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 51 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 52 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 53 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2022-2030 (USD MILLION)
TABLE 54 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 55 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2022-2030 (USD MILLION)
TABLE 56 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2022-2030 (USD MILLION)
TABLE 57 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 58 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2022-2030 (USD MILLION)
TABLE 59 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2022-2030 (USD MILLION)
TABLE 60 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 61 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 62 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 63 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2022-2030 (USD MILLION)
TABLE 64 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2022-2030 (USD MILLION)
TABLE 65 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 66 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2022-2030 (USD MILLION)
TABLE 67 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 68 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2022-2030 (USD MILLION)
TABLE 69 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2022-2030 (USD MILLION)
TABLE 70 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2022-2030 (USD MILLION)
TABLE 71 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2022-2030 (USD MILLION)
TABLE 72 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 73 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 74 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2022-2030 (USD MILLION)
TABLE 75 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2022-2030 (USD MILLION)
TABLE 76 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2022-2030 (USD MILLION)
TABLE 77 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2022-2030 (USD MILLION)
TABLE 78 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 79 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2022-2030 (USD MILLION)
TABLE 80 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2022-2030 (USD MILLION)
TABLE 81 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2022-2030 (USD MILLION)
TABLE 82 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 83 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 84 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 85 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 86 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2022-2030 (USD MILLION)
TABLE 87 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2022-2030 (USD MILLION)
TABLE 88 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2022-2030 (USD MILLION)
TABLE 89 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 90 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 91 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 92 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 93 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 94 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2022-2030 (USD MILLION)
TABLE 95 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2022-2030 (USD MILLION)
TABLE 96 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2022-2030 (USD MILLION)
TABLE 97 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 98 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 99 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2022-2030 (USD MILLION)
TABLE 100 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 101 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 102 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 103 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 104 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 105 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 106 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2022-2030 (USD MILLION)
TABLE 107 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 108 AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 109 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 110 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 111 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 112 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 113 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 114 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 115 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 116 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2022-2030 (USD MILLION)
TABLE 117 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 118 AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 119 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 120 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 121 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 122 AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2022-2030 (USD MILLION)
TABLE 123 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2022-2030 (USD MILLION)
TABLE 124 AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION, 2022-2030 (USD MILLION)
TABLE 125 AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 126 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 127 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2022-2030 (USD MILLION)
TABLE 128 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 129 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2022-2030 (USD MILLION)
TABLE 130 AI IN HEALTHCARE MARKET FOR CONVULATIONAL NEURAL NETWORKS (CNN), BY REGION, 2022-2030 (USD MILLION)
TABLE 131 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN), BY REGION, 2022-2030 (USD MILLION)
TABLE 132 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN), BY REGION, 2022-2030 (USD MILLION)
TABLE 133 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2022-2030 (USD MILLION)
TABLE 134 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2022-2030 (USD MILLION)
TABLE 135 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2022-2030 (USD MILLION)
TABLE 136 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2022-2030 (USD MILLION)
TABLE 137 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2022-2030 (USD MILLION)
TABLE 138 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2022-2030 (USD MILLION)
TABLE 139 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY TYPE, 2022-2030 (USD MILLION)
TABLE 140 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2022-2030 (USD MILLION)
TABLE 141 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 142 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2022-2030 (USD MILLION)
TABLE 143 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2022-2030 (USD MILLION)
TABLE 144 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 145 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 146 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2022-2030 (USD MILLION)
TABLE 147 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 148 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2022-2030 (USD MILLION)
TABLE 149 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2022-2030 (USD MILLION)
TABLE 150 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2022-2030 (USD MILLION)
TABLE 151 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2022-2030 (USD MILLION)
TABLE 152 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2022-2030 (USD MILLION)
TABLE 153 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2022-2030 (USD MILLION)
TABLE 154 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 155 AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 156 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 157 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 158 AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
TABLE 159 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 160 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 161 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 162 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 163 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 164 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 165 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 166 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 167 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 168 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2022-2030 (USD MILLION)
TABLE 169 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 170 AI IN HEALTHCARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 171 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 172 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 173 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 174 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 175 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 176 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 177 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 178 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 179 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 180 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 181 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 182 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 183 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 184 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 185 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 186 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 187 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 188 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 189 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 190 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 191 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 192 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 193 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 194 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 195 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 196 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 197 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 198 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 199 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 200 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 201 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 202 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 203 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 204 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 205 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 206 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 207 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 208 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 209 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 210 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 211 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 212 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 213 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 214 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 215 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 216 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 217 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 218 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 219 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 220 US: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 221 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 222 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 223 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 224 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 225 US: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 226 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 227 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 228 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 229 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 230 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 231 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 232 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 233 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 234 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 235 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 236 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 237 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 238 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 239 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 240 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 241 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 242 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 243 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 244 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 245 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 246 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 247 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 248 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 249 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 250 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 251 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 252 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 253 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 254 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 255 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 256 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 257 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 258 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 259 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 260 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 261 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 262 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 263 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 264 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 265 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 266 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 267 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 268 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 269 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 270 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 271 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 272 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 273 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 274 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 275 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 276 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 277 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 278 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 279 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 280 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 281 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 282 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 283 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 284 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 285 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 286 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 287 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 288 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 289 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 290 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 291 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 292 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 293 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 294 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 295 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 296 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 297 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 298 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 299 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 300 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 301 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 302 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 303 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 304 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 305 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 306 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 307 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 308 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 309 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 310 GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 311 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 312 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 313 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 314 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 315 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 316 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 317 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 318 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 319 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 320 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 321 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 322 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 323 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 324 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 325 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 326 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 327 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 328 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 329 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 330 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 331 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 332 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 333 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 334 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 335 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 336 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 337 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 338 UK: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 339 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 340 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 341 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 342 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 343 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 344 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 345 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 346 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 347 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 348 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 349 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 350 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 351 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 352 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 353 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 354 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 355 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 356 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 357 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 358 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 359 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 360 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 361 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 362 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 363 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 364 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 365 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 366 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 367 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 368 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 369 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 370 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 371 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 372 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 373 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 374 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 375 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 376 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 377 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 378 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 379 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 380 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 381 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 382 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 383 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 384 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 385 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 386 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 387 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 388 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 389 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 390 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 391 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 392 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 393 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 394 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 395 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 396 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 397 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 398 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 399 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 400 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 401 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 402 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 403 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 404 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 405 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 406 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 407 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 408 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 409 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 410 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 411 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 412 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 413 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 414 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 415 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 416 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 417 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 418 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 419 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 420 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 421 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 422 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 423 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 424 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 425 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 426 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 427 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 428 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 429 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 430 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 431 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 432 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 433 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 434 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 435 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 436 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 437 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 438 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 439 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 440 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 441 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 442 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 443 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 444 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 445 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 446 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 447 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 448 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 449 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 450 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 451 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 452 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 453 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 454 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 455 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 456 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 457 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 458 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 459 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 460 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 461 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 462 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 463 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 464 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 465 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 466 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 467 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 468 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 469 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 470 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 471 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 472 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 473 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 474 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 475 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 476 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 477 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 478 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 479 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 480 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 481 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 482 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 483 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 484 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 485 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 486 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 487 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 488 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 489 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 490 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 491 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 492 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 493 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 494 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 495 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 496 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 497 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 498 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 499 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 500 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 501 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 502 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 503 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 504 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 505 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 506 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 507 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 508 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 509 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 510 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 511 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 512 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 513 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 514 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 515 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 516 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 517 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 518 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 519 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 520 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 521 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 522 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 523 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 524 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 525 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 526 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 527 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 528 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 529 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 530 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 531 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 532 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 533 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 534 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 535 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 536 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 537 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 538 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 539 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 540 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 541 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 542 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 543 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 544 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 545 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 546 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 547 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 548 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 549 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 550 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 551 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 552 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 553 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 554 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 555 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 556 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 557 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 558 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 559 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 560 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 561 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 562 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 563 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 564 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 565 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 566 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 567 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 568 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 569 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 570 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 571 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 572 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 573 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 574 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 575 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 576 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 577 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 578 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 579 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 580 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 581 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 582 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 583 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 584 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 585 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 586 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 587 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 588 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 589 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 590 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 591 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 592 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 593 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 594 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 595 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 596 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 597 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 598 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 599 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 600 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 601 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 602 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 603 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 604 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 605 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 606 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 607 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 608 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 609 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 610 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 611 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 612 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 613 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 614 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 615 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 616 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 617 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 618 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 619 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 620 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 621 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 622 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 623 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 624 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 625 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 626 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 627 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 628 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 629 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 630 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 631 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 632 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 633 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 634 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 635 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 636 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 637 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 638 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 639 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 640 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 641 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 642 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 643 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 644 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 645 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 646 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 647 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 648 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 649 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 650 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 651 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 652 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 653 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 654 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 655 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 656 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 657 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 658 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 659 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 660 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 661 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 662 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 663 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 664 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 665 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 666 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 667 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 668 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 669 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 670 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 671 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 672 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 673 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 674 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 675 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 676 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 677 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 678 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE 2022-2030 (USD MILLION)
TABLE 679 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 680 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 681 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 682 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 683 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 684 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 685 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 686 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 687 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 688 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 689 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 690 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 691 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 692 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 693 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 694 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 695 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 696 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 697 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 698 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 699 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 700 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 701 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 702 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 703 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 704 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 705 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 706 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 707 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 708 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 709 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 710 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 711 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 712 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 713 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 714 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 715 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 716 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 717 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 718 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 719 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 720 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 721 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 722 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 723 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 724 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 725 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 726 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 727 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 728 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 729 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 730 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 731 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 732 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 733 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 734 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 735 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 736 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 737 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 738 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 739 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 740 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 741 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 742 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 743 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 744 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 745 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 746 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 747 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 748 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 749 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 750 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 751 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 752 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 753 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 754 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 755 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 756 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 757 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 758 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 759 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 760 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 761 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 762 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 763 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 764 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
TABLE 765 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 766 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 767 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 768 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 769 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 770 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 771 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022-2030 (USD MILLION)
TABLE 772 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 773 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 774 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 775 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 776 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 777 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022-2030 (USD MILLION)
TABLE 778 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 779 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 780 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 781 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 782 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 783 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
TABLE 784 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022-2030 (USD MILLION)
TABLE 785 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 786 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 787 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 788 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 789 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 790 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 791 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 792 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2021-NOVEMBER 2024
TABLE 793 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE ANALYSIS, 2023
TABLE 794 AI IN HEALTHCARE MARKET: REGION FOOTPRINT
TABLE 795 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT
TABLE 796 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT
TABLE 797 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT
TABLE 798 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT
TABLE 799 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT
TABLE 800 AI IN HEALTHCARE MARKET: END-USER FOOTPRINT
TABLE 801 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 802 AI IN HEALTHCARE MARKET: REGION FOOTPRINT (STARTUPS/SMES)
TABLE 803 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 804 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 805 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
TABLE 806 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 807 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
TABLE 808 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 809 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 810 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
TABLE 811 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
TABLE 812 MICROSOFT CORPORATION: COMPANY OVERVIEW
TABLE 813 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 814 MICROSOFT CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 815 MICROSOFT CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 816 NVIDIA CORPORATION: COMPANY OVERVIEW
TABLE 817 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 818 NVIDIA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 819 NVIDIA CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 820 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 821 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
TABLE 822 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-NOVEMBER 2024
TABLE 823 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 824 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
TABLE 825 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 826 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 827 GE HEALTHCARE: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 828 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 829 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 830 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 831 ORACLE: COMPANY OVERVIEW
TABLE 832 ORACLE: PRODUCTS & SERVICES OFFERED
TABLE 833 ORACLE: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
TABLE 834 ORACLE: DEALS, JANUARY 2021-MARCH 2024
TABLE 835 VERADIGM LLC: COMPANY OVERVIEW
TABLE 836 VERADIGM LLC: PRODUCTS & SERVICES OFFERED
TABLE 837 VERADIGM LLC: DEALS, JANUARY 2021-MARCH 2024
TABLE 838 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW
TABLE 839 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 840 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
TABLE 841 AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2021-MARCH 2024
TABLE 842 IBM: COMPANY OVERVIEW
TABLE 843 MERATIVE: PRODUCTS & SERVICES OFFERED
TABLE 844 MERATIVE: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 845 MERATIVE: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 846 MEDTRONIC: COMPANY OVERVIEW
TABLE 847 MEDTRONIC: PRODUCTS & SERVICES OFFERED
TABLE 848 MEDTRONIC: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 849 GOOGLE: COMPANY OVERVIEW
TABLE 850 GOOGLE: PRODUCTS & SERVICES OFFERED
TABLE 851 GOOGLE: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 852 GOOGLE: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 853 GOOGLE: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
TABLE 854 SOPHIA GENETICS: COMPANY OVERVIEW
TABLE 855 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED
TABLE 856 SOPHIA GENETICS: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 857 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
TABLE 858 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 859 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 860 TEMPUS: COMPANY OVERVIEW
TABLE 861 TEMPUS: PRODUCTS & SERVICES OFFERED
TABLE 862 TEMPUS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-NOVEMBER 2024
TABLE 863 TEMPUS: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 864 CONCERTAI: COMPANY OVERVIEW
TABLE 865 CONCERTAI: PRODUCTS & SERVICES OFFERED
TABLE 866 CONCERTAI: PRODUCT LAUNCHES & UPGRADES, JANUARY 2021-NOVEMBER 2024
TABLE 867 CONCERTAI: DEALS, JANUARY 2021-MARCH 2024
TABLE 868 3M: COMPANY OVERVIEW
TABLE 869 3M: PRODUCTS & SERVICES OFFERED
TABLE 870 3M: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 871 COGNIZANT: COMPANY OVERVIEW
TABLE 872 COGNIZANT: PRODUCTS & SERVICES OFFERED
TABLE 873 COGNIZANT: PRODUCT LAUNCHES & UPGRADES, JANUARY 2021-NOVEMBER 2024
TABLE 874 COGNIZANT: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 875 VIZ.AI, INC.: COMPANY OVERVIEW
TABLE 876 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED
TABLE 877 VIZ.AI, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
TABLE 878 VIZ.AI, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
TABLE 879 VIZ.AI, INC.: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
TABLE 880 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW
TABLE 881 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
TABLE 882 RIVERAIN TECHNOLOGIES: DEALS, JANUARY 2021-NOVEMBER 2024

List of Figures

FIGURE 1 AI IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN HEALTHCARE
FIGURE 7 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 AI IN HEALTHCARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION)
FIGURE 12 AI IN HEALTHCARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
FIGURE 13 AI IN HEALTHCARE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
FIGURE 14 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024 VS. 2030 (USD MILLION)
FIGURE 15 AI IN HEALTHCARE MARKET, BY TOOL, 2024 VS. 2030 (USD MILLION)
FIGURE 16 AI IN HEALTHCARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
FIGURE 17 AI IN HEALTHCARE MARKET: REGIONS COVERED
FIGURE 18 RISING NEED FOR EARLY DISEASE DETECTION TO DRIVE MARKET
FIGURE 19 JAPAN TO DOMINATE MARKET IN ASIA PACIFIC IN 2024
FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 21 NORTH AMERICA TO DOMINATE AI IN HEALTHCARE MARKET DURING FORECAST PERIOD
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 23 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24 DATA BREACHES IN HEALTHCARE SECTOR, 2019-2023
FIGURE 25 CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 27 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
FIGURE 28 AI IN HEALTHCARE MARKET: ECOSYSTEM MAPPING
FIGURE 29 AI IN HEALTHCARE MARKET: PATENTS GRANTED, 2013-2023
FIGURE 30 AI IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 33 AI IN HEALTHCARE MARKET: INVESTMENT & FUNDING SCENARIO, 2024
FIGURE 34 GEN AI USE CASES IN HEALTHCARE
FIGURE 35 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT
FIGURE 36 EUROPE: AI IN HEALTHCARE MARKET SNAPSHOT
FIGURE 37 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2019-2023
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2023
FIGURE 40 RANKING OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023
FIGURE 41 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 42 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT
FIGURE 43 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 44 EV/EBITDA OF KEY VENDORS
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 46 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
FIGURE 48 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 49 NVIDIA CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 50 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
FIGURE 52 ORACLE: COMPANY SNAPSHOT (2023)
FIGURE 53 VERADIGM LLC: COMPANY SNAPSHOT (2021)
FIGURE 54 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 55 IBM: COMPANY SNAPSHOT (2023)
FIGURE 56 MEDTRONIC: COMPANY SNAPSHOT (2023)
FIGURE 57 GOOGLE: COMPANY SNAPSHOT (2023)
FIGURE 58 SOPHIA GENETICS: COMPANY SNAPSHOT (2023)
FIGURE 59 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 60 3M: COMPANY SNAPSHOT (2023)
FIGURE 61 COGNIZANT: COMPANY SNAPSHOT (2023)